Jason Haas - Jun 29, 2022 Form 3 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Director
Signature
By: Charles S. Berkman For: Jason Haas
Stock symbol
LGND
Transactions as of
Jun 29, 2022
Transactions value $
$0
Form type
3
Date filed
6/29/2022, 07:33 PM
Previous filing
Feb 17, 2022
Next filing
Oct 11, 2022

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney